Knowledge of genomic testing among early-stage breast cancer patients.

Author

Richman, Alice R

Tzeng, Janice P

Carey, Lisa A

Retèl, Valesca P

Brewer, Noel T

Bibliographic Citation

Psycho-oncology 2011 Jan; 20(1): 28-35

Abstract

Genomic recurrence risk test results now inform clinical decisions about adjuvant treatment for women with early-stage breast cancer. We sought to understand patients' knowledge of these tests and correlates of their knowledge.

Permanent Link

Find Full Text at Georgetown University Library
Full Text from Publisher
http://hdl.handle.net/10822/516063

Date

2011-01

Knowledge of genomic testing among early-stage breast cancer patients.

Author

Bibliographic Citation

Abstract

Permanent Link

Date

Subject

Collections

Metadata

Related items

Predictive Value of Estrogen Receptor Status as Assessed by Ligand-Binding Assay in Patients With Early-Stage Breast Cancer Treated With Breast Conserving Surgery and Radiation Therapy ﻿

Knowledge, attitudes, and utilization of BRCA1/2 testing among women with early-onset breast cancer ﻿

Racial Differences in the Treatment of Early-Stage Lung Cancer ﻿

Predictive Value of Estrogen Receptor Status as Assessed by Ligand-Binding Assay in Patients With Early-Stage Breast Cancer Treated With Breast Conserving Surgery and Radiation Therapy

Knowledge, attitudes, and utilization of BRCA1/2 testing among women with early-onset breast cancer

Racial Differences in the Treatment of Early-Stage Lung Cancer